VEGF levels in humans and animal models with RDS and BPD: temporal relationships.
about
Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary DysplasiaRole of Nitric Oxide Isoforms in Vascular and Alveolar Development and Lung Injury in Vascular Endothelial Growth Factor Overexpressing Neonatal Mice LungsPostnatal inflammation in the pathogenesis of bronchopulmonary dysplasiaAnimal models of bronchopulmonary dysplasia. The term mouse modelsVascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells.Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease.The role of hyperoxia in the pathogenesis of experimental BPD.Gestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamineAnimal models of bronchopulmonary dysplasia. The preterm and term rabbit models.Engineering de novo assembly of fetal pulmonary organoids.The BPD trio? Interaction of dysregulated PDGF, VEGF, and TGF signaling in neonatal chronic lung disease.Effects of Hyperoxia on the Developing Airway and Pulmonary Vasculature.Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells.Effects and molecular mechanisms of intrauterine infection/inflammation on lung development.A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases.
P2860
Q26770515-9EE22263-DFF2-4A2E-887D-F0B232FC5F54Q27325721-F201C478-ACA3-4C42-896F-647CC2BDFE48Q33622213-25516659-D83B-4068-AB53-524F577967CFQ34726840-F331CF35-CCAA-4BBE-B933-74446DE9B8ECQ34789755-8C76DA4D-CA9C-4063-822E-045D9D832A3CQ35606019-9411CA90-DC9E-41F1-A973-B6C6C8E55F0EQ35919587-61142F9D-8C21-4FA8-9D48-B52A4D5621FBQ36768191-2F1A4E8C-6E52-4AA0-96C6-35C86FE22A2CQ37072637-157275F3-1042-44FD-8B3E-0E2498DFD8E8Q38261188-2163F212-89B3-4822-B6F7-6A171A40F837Q42549896-2C299D3F-FDB3-4CAC-9797-158D697A060FQ46326148-1C0063F9-F7DA-48DD-8AB3-47F62AD1EB21Q47431365-B5537B26-B9DB-4200-BDD0-5C5B1B4F2AF6Q49513925-DBB2A906-787A-4CCA-83DF-7D3133EA04A2Q54202794-980F54A5-4E0F-427E-91A4-4066F79FA897Q55293851-1D26F1AF-9CEA-4B9B-8765-29A48BAF36B3
P2860
VEGF levels in humans and animal models with RDS and BPD: temporal relationships.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
VEGF levels in humans and animal models with RDS and BPD: temporal relationships.
@en
type
label
VEGF levels in humans and animal models with RDS and BPD: temporal relationships.
@en
prefLabel
VEGF levels in humans and animal models with RDS and BPD: temporal relationships.
@en
P2860
P1476
VEGF levels in humans and animal models with RDS and BPD: temporal relationships.
@en
P2093
Stephanie Meller
Vineet Bhandari
P2860
P304
P356
10.3109/01902148.2012.663454
P577
2012-03-06T00:00:00Z